scispace - formally typeset
M

Min-Han Tan

Researcher at Agency for Science, Technology and Research

Publications -  186
Citations -  10277

Min-Han Tan is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Cancer & Renal cell carcinoma. The author has an hindex of 40, co-authored 173 publications receiving 8967 citations. Previous affiliations of Min-Han Tan include Singapore General Hospital & National Center for Charitable Statistics.

Papers
More filters
Journal ArticleDOI

Parafibromin expression in breast cancer: a novel marker for prognostication?

TL;DR: Parafibromin in breast cancer, as in parathyroid tumours, appears to have tumour suppressor functions, with loss of protein expression associated with adverse pathological parameters, which may indicate a potential role of parafIBromin as a prognostic marker in Breast cancer.
Journal ArticleDOI

Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma.

TL;DR: GST-alpha was demonstrated as a biomarker for clear cell RCCs through cDNA microarrays and immunohistochemical analysis, demonstrating strong and diffuse GST-alpha immunoreactivity.
Journal ArticleDOI

Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.

TL;DR: This study establishes the first patient-specific HLC-based platform for idiosyncratic hepatotoxicity testing, incorporating multiple potential causative factors and permitting the correlation of transcriptomic and cellular responses to clinical phenotypes.
Journal ArticleDOI

Overexpression of Glutathione S-Transferase α in Clear Cell Renal Cell Carcinoma

TL;DR: GST-α was demonstrated as a biomarker for clear cell RCCs through cDNA microarrays and immunohistochemical analysis, demonstrating strong and diffuse GST-α immunoreactivity.
Journal ArticleDOI

Phenformin-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivo

TL;DR: In vivo studies conducted in an H460 human lung cancer mouse model, it was demonstrated that the drug-loaded micelles had greater anti-tumor efficacy, and reduced the population of SP cells in the tumor tissues more effectively than free phenformin.